Forsta AP Fonden Increases Stock Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Forsta AP Fonden lifted its stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 5.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 88,700 shares of the company’s stock after buying an additional 4,800 shares during the quarter. Forsta AP Fonden’s holdings in Church & Dwight were worth $9,289,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of CHD. Mirae Asset Global Investments Co. Ltd. boosted its stake in Church & Dwight by 22.9% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,749 shares of the company’s stock valued at $2,792,000 after acquiring an additional 4,991 shares in the last quarter. Cromwell Holdings LLC lifted its holdings in shares of Church & Dwight by 36.7% in the 3rd quarter. Cromwell Holdings LLC now owns 686 shares of the company’s stock valued at $72,000 after purchasing an additional 184 shares during the last quarter. Elwood & Goetz Wealth Advisory Group LLC purchased a new stake in shares of Church & Dwight in the 3rd quarter valued at about $367,000. Ballentine Partners LLC boosted its position in shares of Church & Dwight by 13.1% in the 3rd quarter. Ballentine Partners LLC now owns 11,062 shares of the company’s stock valued at $1,158,000 after purchasing an additional 1,285 shares during the period. Finally, Nicholson Wealth Management Group LLC purchased a new position in Church & Dwight during the 3rd quarter worth approximately $728,000. Institutional investors and hedge funds own 86.60% of the company’s stock.

Church & Dwight Trading Down 1.7 %

Shares of CHD opened at $100.84 on Monday. Church & Dwight Co., Inc. has a twelve month low of $82.25 and a twelve month high of $110.31. The company has a current ratio of 1.53, a quick ratio of 0.98 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $24.66 billion, a P/E ratio of 32.01, a PEG ratio of 3.80 and a beta of 0.54. The firm’s 50-day moving average is $102.94 and its two-hundred day moving average is $104.06.

Church & Dwight (NYSE:CHD) last released its quarterly earnings results on Friday, August 2nd. The company reported $0.93 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.09. The business had revenue of $1.51 billion for the quarter, compared to analysts’ expectations of $1.51 billion. Church & Dwight had a return on equity of 19.86% and a net margin of 13.38%. The company’s revenue was up 3.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.92 EPS. On average, research analysts predict that Church & Dwight Co., Inc. will post 3.43 earnings per share for the current fiscal year.

Church & Dwight Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 3rd. Investors of record on Thursday, August 15th were given a $0.2838 dividend. The ex-dividend date was Thursday, August 15th. This represents a $1.14 annualized dividend and a dividend yield of 1.13%. Church & Dwight’s dividend payout ratio is presently 35.87%.

Insider Activity at Church & Dwight

In other Church & Dwight news, EVP Barry A. Bruno sold 59,328 shares of the company’s stock in a transaction dated Monday, August 5th. The shares were sold at an average price of $99.37, for a total value of $5,895,423.36. Following the sale, the executive vice president now owns 4,319 shares of the company’s stock, valued at $429,179.03. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.00% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Evercore ISI decreased their price objective on Church & Dwight from $110.00 to $101.00 and set an “in-line” rating for the company in a report on Monday, August 5th. TD Cowen initiated coverage on shares of Church & Dwight in a research note on Tuesday, July 23rd. They set a “buy” rating and a $116.00 price target for the company. Truist Financial lowered their price objective on shares of Church & Dwight from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, August 5th. JPMorgan Chase & Co. upped their target price on shares of Church & Dwight from $97.00 to $98.00 and gave the company an “underweight” rating in a report on Friday, October 11th. Finally, Barclays increased their target price on shares of Church & Dwight from $82.00 to $86.00 and gave the stock an “underweight” rating in a research note on Friday, October 11th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and eight have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $107.50.

Church & Dwight Company Profile

Church & Dwight Co, Inc develops, manufactures, and markets household, personal care, and specialty products. It operates in three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and showerheads under the WATERPIK brand; cold shortening and relief products under the ZICAM brand; oral care products under the THERABREATH brand; and acne treatment products under the HERO brand.